Testing effectiveness (Phase 2)Ended earlyNCT00258726
What this trial is testing
Immune Responses to Two Dose Varivax +/- MMR-II
Who this might be right for
MeaslesMumpsRubella+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 105